MiNK Therapeutics, Inc. (INKT)
(Delayed Data from NSDQ)
$14.53 USD
+1.31 (9.91%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $14.52 -0.01 (-0.07%) 5:40 PM ET
3-Hold of 5 3
D Value A Growth D Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, MiNK Therapeutics, Inc. has a market cap of $52.69M, which represents its share price of $13.22 multiplied by its outstanding shares number of 3.99M. As a small-cap company, INKT's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
INKT 14.53 +1.31(9.91%)
Will INKT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for INKT based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for INKT
MiNK Therapeutics to Provide Corporate Update and First Quarter 2025 Financial Report | INKT ...
12 Health Care Stocks Moving In Tuesday's Intraday Session
INKT: Analyst Downgrades MiNK Therapeutics to Neutral | INKT Stock News
MiNK Therapeutics (INKT) Downgraded to Neutral Amidst Valuation Concerns | INKT Stock News
MiNK Therapeutics (INKT) Downgraded by Analyst with Price Target Set | INKT Stock News